Close Menu
Global News HQ
    What's Hot

    Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000

    July 29, 2025

    I Swear By the $10 Pain Relief Gel Shoppers Say Makes Aches and Soreness ‘Disappear’

    July 29, 2025

    The first company to complete a fully successful lunar landing is going public

    July 29, 2025
    Recent Posts
    • Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000
    • I Swear By the $10 Pain Relief Gel Shoppers Say Makes Aches and Soreness ‘Disappear’
    • The first company to complete a fully successful lunar landing is going public
    • We Swept Up 3 Weeks’ Worth of Debris to Find the 7 Best Brooms 
    • Client Challenge
    Facebook X (Twitter) Instagram YouTube TikTok
    Trending
    • Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000
    • I Swear By the $10 Pain Relief Gel Shoppers Say Makes Aches and Soreness ‘Disappear’
    • The first company to complete a fully successful lunar landing is going public
    • We Swept Up 3 Weeks’ Worth of Debris to Find the 7 Best Brooms 
    • Client Challenge
    • Whistle pet trackers are shutting down next month
    • Chase Sapphire Preferred vs. Amex Gold: Which card is best? – The Points Guy
    • Interactive Brokers weighs launching customer stablecoin to power 24/7 funding
    Global News HQ
    • Technology & Gadgets
    • Travel & Tourism (Luxury)
    • Health & Wellness (Specialized)
    • Home Improvement & Remodeling
    • Luxury Goods & Services
    • Home
    • Finance & Investment
    • Insurance
    • Legal
    • Real Estate
    • More
      • Cryptocurrency & Blockchain
      • E-commerce & Retail
      • Business & Entrepreneurship
      • Automotive (Car Deals & Maintenance)
    Global News HQ
    Home - Finance & Investment - Why AstraZeneca Stock Topped the Market on Tuesday | The Motley Fool
    Finance & Investment

    Why AstraZeneca Stock Topped the Market on Tuesday | The Motley Fool

    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Why AstraZeneca Stock Topped the Market on Tuesday | The Motley Fool
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Trading in AstraZeneca‘s (AZN 2.26%) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly liked that idea, as they bid those ADSes up by more than 2% that trading session. With that rise, it did better than the S&P 500 (^GSPC -0.11%), which closed the day marginally (0.1%) lower.

    Bye-bye Britain?

    That morning, U.K. newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to move the company’s stock market listing onto our shores (ADSes are certificates conferring ownership of a stock, not the stock itself).

    Image source: Getty Images.

    Citing unidentified multiple sources, the newspaper wrote that Soriot might also be mulling a move of AstraZeneca’s headquarters from the U.K. to the U.S.

    Currently, the global healthcare company is a component of the FTSE 100, considered by many to be the most important U.K. stock index.

    According to The Times‘ reporting, the chief executive is “known to be deeply frustrated with the U.K.’s operating environment.” The newspaper added that he has publicly expressed concern about what he perceives to be a decline in European competitiveness against the U.S. and China. The pair happens to be the company’s two largest markets.

    Neither Soriot nor AstraZeneca has yet officially commented on the article.

    Land of opportunity

    Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market listing and even the headquarters here. It’s unclear (at least for now) how much this might affect the company’s fundamentals and operations, but as a concept, it’s a good idea.

    Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.

    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleAntihistamines for PMDD: What to Know
    Next Article Elon Musk’s Companies at Risk as He Reignites Feud With Trump

    Related Posts

    Client Challenge

    July 29, 2025

    Stocks Close Mixed to Start Fed Week: Stock Market Today

    July 29, 2025

    PPA: The Trend And Fundamentals Remain Bullish (NYSEARCA:PPA)

    July 28, 2025

    2 Brilliant LNG Stocks to Buy Now and Hold for the Long Term | The Motley Fool

    July 28, 2025
    Leave A Reply Cancel Reply

    ads
    Don't Miss
    Cryptocurrency & Blockchain
    3 Mins Read

    Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000

    Yesterday, Bitcoin (BTC) once again faced rejection around the $120,000 resistance level after briefly reaching…

    I Swear By the $10 Pain Relief Gel Shoppers Say Makes Aches and Soreness ‘Disappear’

    July 29, 2025

    The first company to complete a fully successful lunar landing is going public

    July 29, 2025

    We Swept Up 3 Weeks’ Worth of Debris to Find the 7 Best Brooms 

    July 29, 2025
    Top
    Cryptocurrency & Blockchain
    3 Mins Read

    Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000

    Yesterday, Bitcoin (BTC) once again faced rejection around the $120,000 resistance level after briefly reaching…

    I Swear By the $10 Pain Relief Gel Shoppers Say Makes Aches and Soreness ‘Disappear’

    July 29, 2025

    The first company to complete a fully successful lunar landing is going public

    July 29, 2025
    Our Picks
    Cryptocurrency & Blockchain
    3 Mins Read

    Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000

    Yesterday, Bitcoin (BTC) once again faced rejection around the $120,000 resistance level after briefly reaching…

    Health & Wellness (Specialized)
    3 Mins Read

    I Swear By the $10 Pain Relief Gel Shoppers Say Makes Aches and Soreness ‘Disappear’

    Staying active is incredibly rewarding. But let’s face it: It often comes with a good…

    Pages
    • About Us
    • Contact Us
    • Disclaimer
    • Homepage
    • Privacy Policy
    Facebook X (Twitter) Instagram YouTube TikTok
    • Home
    © 2025 Global News HQ .

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version